A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.

Zhang, HuaiHuaiZhangTargher, GiovanniGiovanniTargherByrne, Christopher DChristopher DByrneKim, Seung UpSeung UpKimWong, Vincent Wai-SunVincent Wai-SunWongValenti, LucaLucaValentiGlickman, MyerMyerGlickmanPonce, JaimeJaimePonceMantzoros, Christos SChristos SMantzorosCrespo, JavierJavierCrespoGronbaek, HenningHenningGronbaekYang, WahWahYangEslam, MohammedMohammedEslamWong, Robert JRobert JWongMachado, Mariana VerdelhoMariana VerdelhoMachadoYu, Ming-LungMing-LungYuGhanem, Omar MOmar MGhanemOkanoue, TakeshiTakeshiOkanoueLiu, Jun-FengJun-FengLiuLee, Yong-HoYong-HoLeeXu, Xiao-YuanXiao-YuanXuPan, QiuweiQiuweiPanSui, MeiliMeiliSuiLonardo, AmedeoAmedeoLonardoYilmaz, YusufYusufYilmazZhu, Li-YongLi-YongZhuMoreno, ChristopheChristopheMorenoMiele, LucaLucaMieleCHUN-JEN LIUJIA-HORNG KAOet al.2024-12-032024-12-032024-08https://scholars.lib.ntu.edu.tw/handle/123456789/723514With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11. Using the Qualtrics XM and WJX platforms, questionnaires were sent online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant association members. A total of 890 international experts in various fields from 61 countries responded to the survey. We also achieved full coverage of provincial-level administrative regions in China. 77.1% of respondents agreed that MAFLD should be represented in ICD-11 by updating NAFLD, with no significant regional differences (77.3% in Asia and 76.6% in non-Asia, p = 0.819). Over 80% of respondents agreed or somewhat agreed with the need to assign specific codes for progressive stages of MAFLD (i.e. steatohepatitis) (92.2%), MAFLD combined with comorbidities (84.1%), or MAFLD subtypes (i.e., lean, overweight/obese, and diabetic) (86.1%). This global survey by a collaborative panel of clinical, coding, health management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.enGlobal surveyICD-11MAFLD[SDGs]SDG3A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.journal article10.1007/s12072-024-10702-538878111